» Articles » PMID: 35643554

An Algorithm to Identify Cases of Pulmonary Arterial Hypertension from the Electronic Medical Record

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2022 Jun 1
PMID 35643554
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Study of pulmonary arterial hypertension (PAH) in claims-based (CB) cohorts may facilitate understanding of disease epidemiology, however previous CB algorithms to identify PAH have had limited test characteristics. We hypothesized that machine learning algorithms (MLA) could accurately identify PAH in an CB cohort.

Methods: ICD-9/10 codes, CPT codes or PAH medications were used to screen an electronic medical record (EMR) for possible PAH. A subset (Development Cohort) was manually reviewed and adjudicated as PAH or "not PAH" and used to train and test MLAs. A second subset (Refinement Cohort) was manually reviewed and combined with the Development Cohort to make The Final Cohort, again divided into training and testing sets, with MLA characteristics defined on test set. The MLA was validated using an independent EMR cohort.

Results: 194 PAH and 786 "not PAH" in the Development Cohort trained and tested the initial MLA. In the Final Cohort test set, the final MLA sensitivity was 0.88, specificity was 0.93, positive predictive value was 0.89, and negative predictive value was 0.92. Persistence and strength of PAH medication use and CPT code for right heart catheterization were principal MLA features. Applying the MLA to the EMR cohort using a split cohort internal validation approach, we found 265 additional non-confirmed cases of suspected PAH that exhibited typical PAH demographics, comorbidities, hemodynamics.

Conclusions: We developed and validated a MLA using only CB features that identified PAH in the EMR with strong test characteristics. When deployed across an entire EMR, the MLA identified cases with known features of PAH.

Citing Articles

Assessing the precision of machine learning for diagnosing pulmonary arterial hypertension: a systematic review and meta-analysis of diagnostic accuracy studies.

Fadilah A, Putri V, Puling I, Willyanto S Front Cardiovasc Med. 2024; 11:1422327.

PMID: 39257851 PMC: 11385608. DOI: 10.3389/fcvm.2024.1422327.


Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare databases.

Didden E, Lu D, Hsi A, Brand M, Hedlin H, Zamanian R Pulm Circ. 2024; 14(1):e12333.

PMID: 38333073 PMC: 10851026. DOI: 10.1002/pul2.12333.


Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working....

Morland K, Gerges C, Elwing J, Visovatti S, Weatherald J, Gillmeyer K Pulm Circ. 2023; 13(4):e12317.

PMID: 38144948 PMC: 10739115. DOI: 10.1002/pul2.12317.


A claims-based, machine-learning algorithm to identify patients with pulmonary arterial hypertension.

Hyde B, Paoli C, Panjabi S, Bettencourt K, Bell Lynum K, Selej M Pulm Circ. 2023; 13(2):e12237.

PMID: 37287599 PMC: 10243208. DOI: 10.1002/pul2.12237.

References
1.
Gillmeyer K, Nunez E, Rinne S, Qian S, Klings E, Wiener R . Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data. Chest. 2020; 159(5):1986-1994. PMC: 8129727. DOI: 10.1016/j.chest.2020.12.010. View

2.
Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

3.
Badesch D, Raskob G, Elliott C, Krichman A, Farber H, Frost A . Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2009; 137(2):376-87. DOI: 10.1378/chest.09-1140. View

4.
Simonneau G, Gatzoulis M, Adatia I, Celermajer D, Denton C, Ghofrani A . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D34-41. DOI: 10.1016/j.jacc.2013.10.029. View

5.
Wijeratne D, Lajkosz K, Brogly S, Lougheed M, Jiang L, Housin A . Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018; 11(2):e003973. PMC: 5819352. DOI: 10.1161/CIRCOUTCOMES.117.003973. View